Foundation Medicine, Inc. (FMI): Earnings News

FMI – Misses EPS loss estimates by $0.09. Slightly beats on revenues.

Key Facts Surrounding This News Item

  • FMI had a POWR Rating of A (Strong Buy) coming into today.
  • FMI was 1.57% above its 10-Day Moving Average coming into today.
  • FMI was 9.04% above its 20-Day Moving Average coming into today.
  • FMI was 14.65% above its 50-Day Moving Average coming into today.
  • FMI was 32.74% above its 100-Day Moving Average coming into today.
  • FMI was 61.32% above its 200-Day Moving Average coming into today.
  • FMI had returned +18.55% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.

More Info About Foundation Medicine, Inc. (FMI)

Foundation Medicine provides various molecular information products in the United States. Its molecular information platform includes proprietary methods and algorithms to analyze specimens across various types of cancer, as well as for incorporating that information into clinical care, and offers genomic information about each patient’s individual cancer, enabling physicians to optimize treatments in clinical practice and biopharmaceutical companies to develop targeted oncology therapies. The company was founded in 2009 and is based in Cambridge, Massachusetts. View our full FMI ticker page with ratings, news, and more.

FMI at a Glance

FMI Current POWR Rating™
Overall POWR Rating™
FMI Current Price $137.00 0.15%
More FMI Ratings, Data, and News

FMI Price Reaction

The day of this event (Mar. 7, 2018)
FMI Closing Price$83.25 2.97%
FMI Volume251,000
5.05% from avg
Leading up to this event
FMI 1-mo return14.68%
After this event
FMI 1-day return1.06%
FMI 3-day return2.12%
FMI 5-day return2.34%

FMI Price Chart

More Foundation Medicine, Inc. (FMI) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All FMI News
Page generated in 1.2667 seconds.